Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM), entreprise biopharmaceutique spécialisée en...
Nomination de Florence Dupré en qualité d’administratrice du Conseil d’Administration Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN...
Revenues and operating income in 2022 of €8.3 M (+110% vs. 2021 proforma), including revenues of €8 M, mainly driven by a €7 M milestone and a...
Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), entreprise biopharmaceutique...
First-in-Man study of ODS-101 in healthy volunteers Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM...
Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), a biopharmaceutical company...
FederAidd a vocation d’interconnecter, dans un espace collaboratif virtuel et international, les différents acteurs de pointe capables...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.